Better Health,
Brighter Future
Newsroom
Careers
Investors
Patients
HCPs
Worldwide
Who We Are
About Takeda
How can we do more for our patients?
Everything at Takeda starts with this question.
Learn more
Company Information
Company Facts
History
Worldwide Offices
Executive Leadership
Positions & Guidelines
Corporate Philosophy
Our People
Corporate Governance
Risk & Crisis Management
Compliance
From the CEO
Contact Us
We have global presence in more than 70 countries.
LEARN MORE
What We Do
Our Business
Takeda continues its transformation into an agile and innovative global pharmaceutical leader, serving the needs of patients and physicians worldwide.
Learn more
Research & Development
Our Pipeline
Takeda Clinical Trial Transparency
Publications of Takeda Research Laboratories
Investigator Initiated Sponsored Research
Therapeutic Areas
Our Products
Alliances & Partnerships
Access to Medicines
Suppliers
Sustainable Procurement
Supplier Code of Conduct
Supplier Diversity
Pharmaceutical Supply Chain Initiative
Supplier Qualification & Due Diligence
We focus on our core therapeutic areas.
LEARN MORE
Our Stories
Our Stories
Find out Takeda's stories related on Innovation, Caring and Heritage
Learn more
Innovation
Quality at Takeda
The Key Elements at the Heart of Our Innovation
Caring
Medicine for the World
Safeguarding Plant Diversity
Takeda at TICAD
Going Beyond Medicines
Change the World
Using Immersive Employee Initiatives to Discover Patient Insights
An Empowered Women-led Workforce
Heritage
Keys to Aging Gracefully
Corporate Responsibility
Takeda's CSR
Takeda is committed to creating corporate value by developing outstanding pharmaceutical products and conducting corporate citizenship activities.
LEARN MORE
Basic Policies on CSR
Human Rights
Labour
Environment
Anti-Corruption
Corporate Citizenship Activities
Global CSR Program 2016
Takeda Initiative
IDEEL Program
HERhealth
Global Relay for Life
Digital Birth Program
Corporate Citizenship Videos
CSR Data Book
CSR Data Book Survey
Watch our new video for Corporate Citizenship Activities
WATCH VIDEO
HOME
Newsroom
News Releases
Share:
Newsroom
News Releases
Featured Topics
Corporate Materials
Social Media
News Releases
Enter
All
Last 12 months
2017
2016
2015
2014
2013
2012
June 2017
June 23, 2017
Jun 23, 2017
Phase 1/2 NINLARO data at EHA
June 23, 2017
Jun 23, 2017
Lundbeck and Takeda recieve Complete Response Letter from the FDA for Trintellix® (vortioxetine) sNDA
June 16, 2017
Jun 16, 2017
Takeda Announces Completion of New Manufacturing Facilities at the Oranienburg Site in Germany
June 07, 2017
Jun 07, 2017
ALCANZA Phase 3 Lancet
June 01, 2017
Jun 01, 2017
Takeda Announces its Participation in GHIT Fund for the Second Phase Replenishment
May 2017
May 31, 2017
May 31, 2017
Construction to Start on GCP2 Production Facility at Takeda Ireland Limited Site in Grange Castle
May 24, 2017
May 24, 2017
EHA ASCO
May 24, 2017
May 24, 2017
NINLARO® Capsules Now Available for the Treatment of Multiple Myeloma in Japan
1
2
3
4
5
TOP
We use cookies to gather web statistics that help us improve our site. We store no personal details.
Accept
Read more
